134 related articles for article (PubMed ID: 37670705)
1. Regulating Tumorigenicity and Cancer Metastasis through TRKA Signaling.
Fan Y; Zhang B; Du X; Wang B; Yan Q; Guo L; Yao W
Curr Cancer Drug Targets; 2024; 24(3):271-287. PubMed ID: 37670705
[TBL] [Abstract][Full Text] [Related]
2. TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties.
Kyker-Snowman K; Hughes RM; Yankaskas CL; Cravero K; Karthikeyan S; Button B; Waters I; Rosen DM; Dennison L; Hunter N; Donaldson J; Christenson ES; Konstantopoulos K; Hurley PJ; Croessmann S; Park BH
Breast Cancer Res Treat; 2020 Feb; 179(3):631-642. PubMed ID: 31823098
[TBL] [Abstract][Full Text] [Related]
3. NGF from pancreatic stellate cells induces pancreatic cancer proliferation and invasion by PI3K/AKT/GSK signal pathway.
Jiang J; Bai J; Qin T; Wang Z; Han L
J Cell Mol Med; 2020 May; 24(10):5901-5910. PubMed ID: 32294802
[TBL] [Abstract][Full Text] [Related]
4. Effect and mechanisms of sacral nerve stimulation on visceral hypersensitivity mediated by nerve growth factor.
Jiang L; Ye B; Wang Y; Yu T; Xu H
J Cell Mol Med; 2019 Dec; 23(12):8019-8024. PubMed ID: 31638328
[TBL] [Abstract][Full Text] [Related]
5. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells.
Eggert A; Ikegaki N; Liu X; Chou TT; Lee VM; Trojanowski JQ; Brodeur GM
Oncogene; 2000 Apr; 19(16):2043-51. PubMed ID: 10803465
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib.
Lin C; Ren Z; Yang X; Yang R; Chen Y; Liu Z; Dai Z; Zhang Y; He Y; Zhang C; Wang X; Cao W; Ji T
Cancer Lett; 2020 Mar; 472():81-96. PubMed ID: 31838083
[TBL] [Abstract][Full Text] [Related]
7. Auricular Vagal Nerve Stimulation Inhibited Central Nerve Growth Factor/Tropomyosin Receptor Kinase A/Phospholipase C-Gamma Signaling Pathway in Functional Dyspepsia Model Rats With Gastric Hypersensitivity.
Zhou JZ; Chen H; Xu WL; Fu Z; Zhou S; Zhu WJ; Zhang ZH
Neuromodulation; 2024 Feb; 27(2):273-283. PubMed ID: 36801128
[TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1.
Zhu W; Oxford GS
Mol Cell Neurosci; 2007 Apr; 34(4):689-700. PubMed ID: 17324588
[TBL] [Abstract][Full Text] [Related]
9. Targeting TRK family proteins in cancer.
Khotskaya YB; Holla VR; Farago AF; Mills Shaw KR; Meric-Bernstam F; Hong DS
Pharmacol Ther; 2017 May; 173():58-66. PubMed ID: 28174090
[TBL] [Abstract][Full Text] [Related]
10. TrkA mediates retrograde semaphorin 3A signaling through plexin A4 to regulate dendritic branching.
Yamashita N; Yamane M; Suto F; Goshima Y
J Cell Sci; 2016 May; 129(9):1802-14. PubMed ID: 26945060
[TBL] [Abstract][Full Text] [Related]
11. NGF/TrkA Signaling as a Therapeutic Target for Pain.
Hirose M; Kuroda Y; Murata E
Pain Pract; 2016 Feb; 16(2):175-82. PubMed ID: 26452158
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TrkA and requires the common neurotrophin receptor P75.
Culmsee C; Gerling N; Lehmann M; Nikolova-Karakashian M; Prehn JH; Mattson MP; Krieglstein J
Neuroscience; 2002; 115(4):1089-108. PubMed ID: 12453482
[TBL] [Abstract][Full Text] [Related]
13. Optical Activation of TrkA Signaling.
Duan L; Hope JM; Guo S; Ong Q; François A; Kaplan L; Scherrer G; Cui B
ACS Synth Biol; 2018 Jul; 7(7):1685-1693. PubMed ID: 29975841
[TBL] [Abstract][Full Text] [Related]
14. Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells.
Bapat AA; Munoz RM; Von Hoff DD; Han H
PLoS One; 2016; 11(10):e0165586. PubMed ID: 27792755
[TBL] [Abstract][Full Text] [Related]
15. NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.
Park DY; Choi C; Shin E; Lee JH; Kwon CH; Jo HJ; Kim HR; Kim HS; Oh N; Lee JS; Park OK; Park E; Park J; Shin JY; Kim JI; Seo JS; Park HD; Park J
Oncotarget; 2016 Feb; 7(7):8399-412. PubMed ID: 26716414
[TBL] [Abstract][Full Text] [Related]
16. Ectopic nerve growth factor prevents proliferation in glioma cells by senescence induction.
Meco D; Di Francesco AM; Melotti L; Ruggiero A; Riccardi R
J Cell Physiol; 2019 May; 234(5):6820-6830. PubMed ID: 30417351
[TBL] [Abstract][Full Text] [Related]
17. Roles of TrkC Signaling in the Regulation of Tumorigenicity and Metastasis of Cancer.
Jin W
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936239
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of nerve growth factor and tropomyosin-receptor-kinase signaling pathway in intrahepatic cholangiocarcinoma.
Yang XQ; Xu YF; Guo S; Liu Y; Ning SL; Lu XF; Yang H; Chen YX
World J Gastroenterol; 2014 Apr; 20(14):4076-84. PubMed ID: 24744599
[TBL] [Abstract][Full Text] [Related]
19. Pro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein.
Demont Y; Corbet C; Page A; Ataman-Önal Y; Choquet-Kastylevsky G; Fliniaux I; Le Bourhis X; Toillon RA; Bradshaw RA; Hondermarck H
J Biol Chem; 2012 Jan; 287(3):1923-31. PubMed ID: 22128158
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of WO2015042088 A1 - a novel urea-based scaffold for TrkA inhibition.
Bernard-Gauthier V; Schirrmacher R
Expert Opin Ther Pat; 2016; 26(2):291-5. PubMed ID: 26561352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
